NEBCINE 25 mg, solution for injection bottle, 2.5 ml
Active ingredients: Tobramycin sulfate, Tobramycin
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 2.5 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NEBCINE 25 mg, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) ampoule(s) en verre de 2,5 ml
- Marketing authorisation holder
- LABORATOIRE XO
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Nov 1974
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67923265CIP73164854CIP133400931648543Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULFATE DE TOBRAMYCINEsolution | — | SA |
| TOBRAMYCINEsolution | 25 mg · un flacon ampoule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.